Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

6.29

0.00 (0.00%)

At close: Jan 2, 2026, 4:00 PM EST

6.25

-0.04 (-0.64%)

After-hours: Jan 2, 2026, 7:20 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M